Literature DB >> 15970513

Platelet aggregation: involvement of thrombin and fibrin(ogen).

Ton Lisman1, Cees Weeterings, Philip G de Groot.   

Abstract

Platelets play a key role in hemostasis and thrombosis. The formation of a platelet plug is accompanied by the generation of thrombin, which results in the generation of fibrin required for stabilization of the platelet plug. Platelet plug formation and coagulation are closely linked processes. Thrombin is a potent platelet activator, which proceeds through proteolysis of the protease activated receptors (PARs). Furthermore, thrombin binds glycoprotein Ib(alpha), which amplifies platelet activation by accelerating PAR-1 activation, and possibly also by direct signaling events through glycoprotein Ib(alpha). Moreover, thrombin's specificity towards other substrates changes after binding glycoprotein Ib(alpha). Fibrinogen and fibrin, the end product of the coagulation cascade, are also involved in platelet aggregation. Both fibrinogen and fibrin bind the integrin alpha(IIb)beta(3), and another fibrin receptor involved in platelet aggregation has been postulated. This review will discuss the role of thrombin and fibrin(ogen) in platelet functioning, and will highlight pathways at the crossroad of coagulation and platelet functioning, which are potential targets for antithrombotic therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15970513     DOI: 10.2741/1715

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  18 in total

1.  Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi.

Authors:  Jaehyung Cho; Deane F Mosher
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

Review 2.  Role of inflammatory markers in corona virus disease (COVID-19) patients: A review.

Authors:  Jyoti Upadhyay; Nidhi Tiwari; Mohd N Ansari
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-07

Review 3.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

4.  Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans.

Authors:  Dafna Groeneveld; David Pereyra; Zwanida Veldhuis; Jelle Adelmeijer; Petra Ottens; Anna K Kopec; Patrick Starlinger; Ton Lisman; James P Luyendyk
Journal:  Blood       Date:  2019-01-17       Impact factor: 22.113

5.  Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice.

Authors:  N Joshi; A K Kopec; K M O'Brien; K L Towery; H Cline-Fedewa; K J Williams; B L Copple; M J Flick; J P Luyendyk
Journal:  J Thromb Haemost       Date:  2014-12-11       Impact factor: 5.824

6.  Improving Blood Compatibility of Intravascular Oxygen Sensors Via Catalytic Decomposition of S-Nitrosothiols to Generate Nitric Oxide In Situ.

Authors:  Yiduo Wu; Alvaro P Rojas; Grant W Griffith; Amy M Skrzypchak; Nathan Lafayette; Robert H Bartlett; Mark E Meyerhoff
Journal:  Sens Actuators B Chem       Date:  2007-01-30       Impact factor: 7.460

Review 7.  Platelets in neutrophil recruitment to sites of inflammation.

Authors:  Simon Pitchford; Dingxin Pan; Heidi C E Welch
Journal:  Curr Opin Hematol       Date:  2017-01       Impact factor: 3.284

8.  Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy.

Authors:  C P D M de Breet; S Zwaveling; M J A Vries; R G van Oerle; Y M C Henskens; A W J Van't Hof; P E J van der Meijden; L Veenstra; H Ten Cate; R H Olie
Journal:  Front Cardiovasc Med       Date:  2021-06-10

9.  Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?

Authors:  Emily N W Yeung; Philipp Treskes; Sarah F Martin; Jonathan R Manning; Donald R Dunbar; Sophie M Rogers; Thierry Le Bihan; K Ann Lockman; Steven D Morley; Peter C Hayes; Leonard J Nelson; John N Plevris
Journal:  Lipids Health Dis       Date:  2015-08-10       Impact factor: 3.876

10.  Platelet dysfunction in injured patients.

Authors:  Noelle N Saillant; Carrie A Sims
Journal:  Mol Cell Ther       Date:  2014-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.